S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in
NASDAQ:MOR

MorphoSys Price Target, Predictions & Analyst Ratings

$24.85
-0.73 (-2.85 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$24.85
Now: $24.85
$25.61
50-Day Range
$25.58
MA: $28.70
$30.66
52-Week Range
$18.21
Now: $24.85
$35.73
Volume74,719 shs
Average Volume38,279 shs
Market Capitalization$3.27 billion
P/E Ratio118.34
Dividend YieldN/A
Beta1.03

Analyst Ratings

MorphoSys (NASDAQ:MOR) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for MorphoSys in the last 12 months. There are currently 5 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
MOR Consensus Rating: HoldHoldHoldBuy
MOR Consensus Rating Score: 2.382.382.292.50
MOR Analyst Ratings: 0 Sell Rating(s)
5 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
MOR Consensus Price Target: N/AN/AN/AN/A
MOR Price Target Upside: N/AN/AN/AN/A

MorphoSys (NASDAQ:MOR) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

MorphoSys (NASDAQ:MOR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/21/2020Berenberg BankReiterated RatingBuyLow
12/7/2020Smith Barney CitigroupReiterated RatingBuyHigh
11/25/2020Morgan StanleyInitiated CoverageEqual WeightMedium
11/18/2020The Goldman Sachs GroupInitiated CoverageNeutralMedium
11/13/2020BarclaysReiterated RatingEqual WeightN/A
8/10/2020CitigroupInitiated CoverageBuyN/A
6/25/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector PerformN/A
5/12/2020HSBCUpgradeReduce ➝ HoldN/A
1/14/2020SVB LeerinkReiterated RatingOutperformHigh
11/27/2019GuggenheimInitiated CoverageBuyN/A
7/18/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuyN/A
11/14/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$32.00 ➝ $34.00N/A
11/5/2018Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$38.00N/A
5/14/2018JMP SecuritiesInitiated CoverageMkt Outperform ➝ Outperform$38.00N/A
(Data available from 2/28/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 2/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.